Biofourmis
Nashville, Tennessee, United States · Artificial Intelligence, Biotechnology, Data And Analytics
Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solution collects and analyzes over 120 biomarkers in real time and identifies shifts that require proactive interventions. This vital innovation enables Biofourmis to offer people everywhere connected access to hospital-level services, virtual provider networks for remote care, and life-changing cl
Key facts
- Headquarters
- Nashville, Tennessee, United States
- Employees
- 334
- Industries
- Artificial Intelligence, Biotechnology, Data And Analytics
- Status
- Private
- Website
- biofourmis.com
- Company page
Recent activity at Biofourmis
- : Biofourmis Partners with Lee Health to Expand Remote Patient Monitoring and Launch Hospital at Home Program
- : Biofourmis Raises Additional Funding From Intel Capital In Series D Extension And Names Top Healthcare Leaders To Its Board
- : Biofourmis Receives Significant Growth Investment From General Atlantic To Propel Company To Unicorn Status
Biofourmis funding history
| Date | Round | Amount |
|---|---|---|
| Aug 2022 | Series D | Undisclosed |
| Apr 2022 | Venture | Undisclosed |
Leadership
- Matt Borowiecki, CFO
Verified email and direct lines for Biofourmis’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Biofourmis files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Biofourmis in the news
- Looking for a hospital-at-home partner? Here’s what to know - Modern Healthcare (Mar 20, 2026)
- Biofourmis expands AI-enabled virtual care to monitor complex chronic conditions - Fierce Healthcare (Feb 14, 2022)
- Remote Health Monitoring Companies CoPilotIQ, Biofourmis Merge - HCI Innovation Group (Oct 30, 2024)
- Novartis taps growing Biofourmis for digital heart failure project - Fierce Biotech (Nov 18, 2019)
- Health AI Startup Biofourmis Hits $1.3 Billion Valuation With Series D Funding - Forbes (Apr 26, 2022)
- Will CMS' Acute Hospital Care at Home waiver program become permanent? - Healthcare IT News (Aug 28, 2023)
- There’s No Place Like Home When It Comes to Oncology Care and Clinical Trials - Fierce Pharma (Apr 24, 2023)
- Start-up that uses wearables to track whether drugs are effective gets $100 million infusion led by SoftBank - CNBC (Sep 02, 2020)
Companies similar to Biofourmis
- Exscientia · Artificial Intelligence, Biotechnology, Data And Analytics, Health Care, Software
- IMPLICITY · Artificial Intelligence, Biotechnology, Data And Analytics, Health Care, Software
- RegASK · Artificial Intelligence, Biotechnology, Health Care, Life Science, Software
- MethodHub Software Limited · Artificial Intelligence, Biotechnology, Health Care, Life Science, Software
- Nucleai · Artificial Intelligence, Biotechnology, Data And Analytics, Health Care, Software
About Biofourmis: questions and answers
What does Biofourmis do?
Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solution collects and analyzes over 120 biomarkers in real time and identifies shifts that require proactive interventions. This vital innovation enables Biofourmis to offer people everywhere connected access to hospital-level services, virtual provider networks for remote care, and life-changing cl
Where is Biofourmis headquartered?
Biofourmis is headquartered in Nashville, Tennessee, United States.
How many employees does Biofourmis have?
Biofourmis has about 334 employees.
Has Biofourmis raised funding?
Yes. Fundz has recorded 2 funding events for Biofourmis. The most recent, Series D of Undisclosed, was in Aug 2022.
What is the latest news on Biofourmis?
On Nov 18, 2024, Biofourmis Partners with Lee Health to Expand Remote Patient Monitoring and Launch Hospital at Home Program
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy